All In Biotech

Drug Trial Radar · NCT06564311

A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Obexelimab in Patients With Relapsing Multiple Sclerosis

Last checked: Nov 19, 2026Latest source record: Nov 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

93

Planned (sponsor's estimate)

Start

Aug 26, 2024

Primary completion

Aug 28, 2025

Study completion Feb 2026

Sponsor

Lead sponsor
Zenas BioPharma (USA), LLCIndustry
Sponsor type
Industry
First posted
Aug 21, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to examine the efficacy and safety of obexelimab in participants with relapsing multiple sclerosis

Conditions

  • Relapsing Multiple Sclerosis

Interventions

  • ObexelimabDrug

    Obexelimab is a monoclonal antibody that simultaneously binds CD19 and FcyRIIb, resulting in down regulation of B cell activity

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cumulative number of new GdE T1 hyperintense lesionsTime frame: Week 8 and Week 12

Locations

47 sites in 12 countries. Site status is shown where the registry gives one.

  • North Central Neurology

    Cullman, Alabama

  • Center for Neurology and Spine

    Phoenix, Arizona

  • Perseverance Research Center

    Scottsdale, Arizona

  • Regina Berkovich MD PhD, Inc

    West Hollywood, California

  • Aqualine Clinical Research

    Naples, Florida

  • University of South Florida

    Tampa, Florida

  • University of Massachusetts Medical School

    Worcester, Massachusetts

  • Infusion Associates Plymouth

    Plymouth, Minnesota

  • MS Center for Innovations in Care

    St Louis, Missouri

  • Holy Name Medical Center

    Teaneck, New Jersey

  • Boster Center for MS

    Columbus, Ohio

  • North Texas Institute of Neurology and Headache

    Plano, Texas

  • Center for Neurological Disorders

    Greenfield, Wisconsin

  • Medical College of Wisconsin

    Milwaukee, Wisconsin

  • Neuro-logisch Wien

    Vienna, Austria

  • Rehabilitation & MS Center, Noorderhart Hospital

    Overpelt, Belgium

  • AZ Delta-Deltalaan 1

    Roeselare, Belgium

  • Tiantan Hospital, Capital Medical University

    Beijing, China

  • The First Affiliation Hospital of Soochow University

    Suzhou, China

  • Tianjin Medical University General Hospital

    Tianjin, China

  • People's Hospital of Xinjiang Uyaur Autonomous Region

    Ürümqi, China

  • Tongji Hospital, Tongji Medical Center of HUST

    Wuhan, China

  • Klinicki bolnicki centar Zagreb

    Zagreb, Croatia

  • Fakultni nemocnice u sv. Anny v Brne

    Brno, Czechia

  • Nemocnice Jihlava

    Jihlava, Czechia

  • General University Hospital Praha

    Prague, Czechia

  • Aalborg Universitetshospital

    Aalborg, Denmark

  • Attikon University General Hospital

    Chaïdári, Greece

  • University General Hospital of Larissa

    Larissa, Greece

  • Fondazione Isituto G. Giglio di Cefalu

    Cefalù, Italy

  • University of Florence

    Florence, Italy

  • Istituto Neurologico Mediterraneo Neuromed

    Pozzilli, Italy

  • Fondazione PTV Policlinico Tor Vergata

    Roma, Italy

  • Neurocentrum Bydgoszcz sp.z o.o.

    Bydgoszcz, Poland

  • M.A. LEK A.M. Maciejowsy Spolka Cywilna

    Katowice, Poland

  • Zanamed Medical Clinic Sp z o.o.

    Lublin, Poland

  • Wielospecjalistyczne Centrum Medyczne Ibismed

    Zabrze, Poland

  • Hospital Clinico San Carlos

    Madrid, Spain

  • Hospital General Universitario Gregorio Marañon

    Madrid, Spain

  • Hospital Regional Universitario de Malaga - Hospital General

    Málaga, Spain

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.